In Brief: Biomagnetic Technologies
This article was originally published in The Gray Sheet
Executive Summary
Biomagnetic Technologies: Magnetic source imaging device company plans restructuring due to "lower short term market projections for its products," the company says. As part of the restructuring, Scott Buchanan will assume the position of president and chief operating officer, replacing James Schumacher who will remain chairman and CEO. Buchanan was previously VP-engineering and applications. An initial staff reduction of 16 employees is expected to be followed by a layoff of 28 more workers after development of the Magnes 2500 WH magnetic source imaging system is completed. Biogmagnetic Technologies also plans on reducing non-personnel related program costs...
You may also be interested in...
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.